Announcements Trials
Browse Landscape

Phase

Phase 2 120Phase 3 60Phase 1 30Phase NA 20Phase 1/2 8Phase 2/3 3Phase 4 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 44INDUSTRY 20OTHER_GOV 4NIH 4NETWORK 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 9Gastrointestinal 7Other hematologic neoplasm 5Lymphoid 4Gynecologic 3Genitourinary 3Sarcoma 2Plasma cell 1Other solid neoplasm 1Head & Neck 1Dermatologic 1CNS 1Breast 1

Conditions

Peritoneal Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Adenocarcinoma 1Carcinoma, Ovarian Epithelial 1

Interventions

Taxes 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Paclitaxel 1Metformin 1Magnetic Resonance Spectroscopy 1Laparoscopy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × NETWORK × Gynecologic × Clear all
NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting
148 enrolled
Gynecologic

Peritoneal Neoplasms

NCT01506856 2023-09-15

iPocc

Gynecologic Oncology Trial & Investigation Consortium

Phase 2/3 Completed
655 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT02065687 2021-09-30

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

GOG Foundation

Phase 2/3 Unknown
469 enrolled 16 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡